Dyslipidemias

The dyslipidemias

Dyslipidemia is defined as any significant abnormality of blood lipids, particularly cholesterol and triglycerides. It is a widespread condition, leading to significantly increased cardiovascular risk and very often requiring a specialized approach, particularly in resistant forms and in coronary artery disease patients on secondary prevention (i.e., who have already suffered an acute cardiovascular event) or at high risk.

Treatment of resistant dyslipidemia

In close collaboration with family physicians, the service ensures comprehensive, personalized and ongoing patient care. The multifactorial picture of the disease (we distinguish familial forms, which can be traced back to a genetic abnormality, and forms more related to the patient's lifestyle) necessitates an integrated approach that includes scrupulous risk assessment, dietary counseling, identification of familial forms also through generic tests, and setting the most effective drug therapy.
In selected cases, new classes of monoclonal drugs are safely prescribed and administered, highly effective treatments that require specialized expertise and periodic follow-up.